Grey
Brand Name(s):Relistor
Indication:Opioid-induced constipation
Rationale:2
Considered:May-08
Review Date:Aug-22
Comments:
NICE is unable to recommend the use in the NHS of methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care because no evidence submission was received from the manufacturer of the technology.
NICE technology appraisal 277
March 2013